• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
NIHR Leicester Biomedical Research Centre

NIHR Leicester Biomedical Research Centre

  • Home
  • About Us
    • Leadership Team
    • How we do it
    • Our NIHR infrastructure
    • Governance
    • Strategy
    • Vacancies
  • Our Research
    • Respiratory and Infection
    • Lifestyle
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Personalised Cancer Prevention and Treatment
    • Environment
    • Cardiovascular
  • Public Involvement
    • Get Involved
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
  • For Researchers
    • The Internal Resource Hub
    • Career Development
    • Current training & funding opportunities
    • Training resources
    • Communicating your research
    • The 2023 Symposium
      • Biographies of today’s speakers
  • News and events
Mar 16, 2021

Pick up the pace! New study finds slow walkers four times more likely to die from Covid-19

Slow walkers are almost four times more likely to die from COVID-19 and have over twice the risk of contracting a severe version of the virus, according to a team of researchers from the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC) led by Professor Tom Yates at the University of Leicester.

The study of 412,596 middle-aged UK Biobank participants examined the relative association of body mass index (BMI) and self-reported walking pace with the risk of contracting severe COVID-19 and COVID-19 mortality.

The analysis found slow walkers of a normal weight to be almost 2.5 times more likely to develop severe COVID-19 and 3.75 times more likely to die from the virus than normal weight fast walkers.

Professor Tom Yates, Lead Researcher for the study and a Professor of Physical Activity, Sedentary Behaviour and Health at the University of Leicester said: “We know already that obesity and frailty are key risk factors for COVID-19 outcomes. This is the first study to show that slow walkers have a much higher risk of contracting severe COVID-19 outcomes, irrespective of their weight.

“With the pandemic continuing to put unprecedented strain on health care services and communities, identifying individuals at greatest risk and taking preventative measures to protect them is crucial.”

A further key finding from this research was that normal weight slow walkers are more at risk for both severe COVID-19 and COVID-19 mortality than fast walkers with obesity. Furthermore, risk was uniformly high in normal weight slow walkers and slow walkers with obesity.

Professor Yates continued: “Fast walkers have been shown to generally have good cardiovascular and heart health, making them more resilient to external stressors, including viral infection but this hypothesis has not yet been established for infectious disease.

“Whilst large routine database studies have reported the association of obesity and fragility with COVID-19 outcomes, routine clinical databases do not currently have data on measures of physical function or fitness.

“It is my view that ongoing public health and research surveillance studies should consider incorporating simple measures of physical fitness such as self-reported walking pace in addition to BMI, as potential risk predictors of COVID-19 outcomes that could ultimately enable better prevention methods that save lives.”

The study ‘Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank’ was published on 26 February 2021 in the International Journal of Obesity. The analysis was restricted to England and outcomes were assessed during the first wave of the pandemic.

Ends

Category: Press ReleasesTag: coronavirus, covid, lifestyle, News, Press Release, walking

Recent News

A group photo of delegates at the recent Respiratory Genomics conference

International scientific event aims to improve treatment for lung diseases

Innovation of the Year Award win for Cardiology Team

Effectiveness of ‘smart’ inhalers in preventing COPD flare ups is focus of new study

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre
University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Our Research

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2027 strategy documents

Governance

Useful links

Our partnerships

Equality, Diversity & Inclusion

Cookie Policy

Copyright © NIHR Leicester Biomedical Research Centre

  • LinkedIn
  • Twitter
  • Facebook